IOVS Brain
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKendrick, A. M.
Right arrow Articles by Fortune, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKendrick, A. M.
Right arrow Articles by Fortune, B.
(Investigative Ophthalmology and Visual Science. 2002;43:1393-1399.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Elevated Vernier Acuity Thresholds in Glaucoma

Allison M. McKendrick1,2, Chris A. Johnson1, Andrew J. Anderson1 and Brad Fortune1

1 From Discoveries in Sight, Devers Eye Institute, Legacy Clinical Research and Technology Center, Portland, Oregon; and the 2 Department of Psychology, University of Western Australia, Nedlands, Western Australia, Australia.

PURPOSE. In 1993, Piltz et al. observed that foveal vernier acuity thresholds for achromatic targets are elevated in patients with glaucoma. This study was undertaken to explore whether such elevated thresholds are present when subject groups are measured with targets of effectively equivalent contrast. Vernier acuity measures were also obtained with short-wavelength and frequency-doubled stimuli, to assess spatial hyperacuity performance in the short-wavelength–sensitive and magnocellular pathways, respectively.

METHODS. Twenty patients with glaucoma and 19 subjects with normal vision participated. All subjects had visual acuity of 20/25 or better. Achromatic two-dot vernier thresholds were obtained for 90% contrast dots. In addition, individual contrast thresholds to the achromatic dots were measured for each subject, and vernier thresholds were measured at 4, 8, 12, and 16 times contrast threshold. Short-wavelength vernier acuity thresholds were measured for blue dots presented on a bright yellow background. The stimulus for the frequency-doubling grating vernier acuity task was a 90% contrast, 1-cyc/deg, 25-Hz sinusoidal grating.

RESULTS. The glaucoma group demonstrated significantly higher foveal vernier acuity thresholds than control subjects for the blue-on-yellow stimulus (P = 0.002) and frequency-doubling grating stimulus (P < 0.001). No significant difference in vernier acuity between groups was found for the 90% contrast achromatic dots (P = 0.09), however a significant difference was found for the normalized contrast targets (P = 0.04).

CONCLUSIONS. Vernier acuity tasks can be used to demonstrate abnormal foveal function in glaucoma. Testing with visual-function–specific stimuli may be effective in identifying such dysfunction. Vernier acuity, or other similar hyperacuity tasks that assess spatial sampling, may be useful in the detection of early glaucomatous damage, before it is detected with traditional perimetric tests.




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
N Gupta, N Krishnadev, S J Hamstra, and Y H Yucel
Depth perception deficits in glaucoma suspects
Br. J. Ophthalmol., August 1, 2006; 90(8): 979 - 981.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Subramanian and C. Dickinson
Spatial Localization in Visual Impairment
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 78 - 85.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. M. McKendrick, D. R. Badcock, and W. H. Morgan
Psychophysical Measurement of Neural Adaptation Abnormalities in Magnocellular and Parvocellular Pathways in Glaucoma
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1846 - 1853.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology